Tag Archives: NASDAQ:LIVN

LivaNova (LIVN) Receives a Rating Update from a Top Analyst

Canaccord Genuity analyst Jason Mills maintained a Hold rating on LivaNova (LIVN – Research Report) today and set a price target of $66.00. The company’s shares closed last Monday at $62.70, close to its 52-week low of $62.48. According to

LivaNova (LIVN) Gets a Buy Rating from Berenberg Bank

Berenberg Bank analyst Scott Bardo maintained a Buy rating on LivaNova (LIVN – Research Report) yesterday and set a price target of $114.00. The company’s shares closed last Monday at $62.70, close to its 52-week low of $62.48. According to

Analysts Offer Insights on Healthcare Companies: LivaNova PLC (NASDAQ: LIVN), Quidel Corp (NASDAQ: QDEL) and ACADIA Pharmaceuticals Inc (NASDAQ: ACAD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LivaNova PLC (LIVN – Research Report), Quidel Corp (QDEL – Research Report) and ACADIA Pharmaceuticals Inc (ACAD – Research Report) with bullish

LivaNova PLC (LIVN) Receives a Buy from Berenberg Bank

In a report issued on September 6, Scott Bardo from Berenberg Bank maintained a Buy rating on LivaNova PLC (LIVN – Research Report), with a price target of $114. The company’s shares closed last Monday at $80.53. Bardo has an

LivaNova PLC (LIVN) Gets a Buy Rating from Needham

In a report released today, Michael Matson from Needham reiterated a Buy rating on LivaNova PLC (LIVN – Research Report), with a price target of $91. The company’s shares closed last Monday at $79.68. According to TipRanks.com, Matson is a

Needham Thinks LivaNova PLC’s Stock is Going to Recover

Needham analyst Michael Matson maintained a Buy rating on LivaNova PLC (LIVN – Research Report) today and set a price target of $87. The company’s shares closed on Friday at $72.27, close to its 52-week low of $64.80. According to